Archives

by in
Entry Author Date Location
Chamath Palihapitiya Wants to Rewire the Crap Out of Healthcare 06/12/13 San Francisco
Regeneron Eyes Potential Blockbuster With Asthma Drug 05/21/13 New York
Sanitas Gets FDA Clearance to Market ‘Wellaho’ for Chronically Ill 02/20/13 San Diego
After Clinical Trial Setback, San Diego’s MediciNova Sets New Course 01/08/13 San Diego
San Diego Life Sciences Roundup: Amylin Buyout, PDUFA, & More 07/05/12 San Diego
SD Life Sciences Roundup: Takeda Consolidates, Startups Raise Cash 05/24/12 San Diego
MediciNova Misses Primary Goal in Mid-Stage Trial of IV Asthma Drug 05/23/12 San Diego
SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More 05/10/12 San Diego
San Diego’s MediciNova Nears Turning Point with Lead Drug for Asthma 05/08/12 San Diego
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug 07/21/11 San Diego
Theravance, Glaxo Lung Drug Passes Two Pivotal Trials; Two More to Go 06/02/11 San Francisco
Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With it 05/26/11 San Francisco
Report: AstraZeneca to Lay Off 135 in MA 05/19/11 Boston
Pfizer Hands Back Rigel Drug 05/06/11 San Francisco
Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails 02/03/11 San Diego
FDA Approves Sunovion Schizophrenia Drug 10/29/10 Boston
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News 10/21/10 San Diego
Boston Scientific to Inhale Asthmatx in $194M Buyout 09/20/10 Boston
NKT Brings In $4M 08/25/10 Boston
How to Find Balance in Biotech, Between Owning It All or Finding a Partner 06/16/10 San Diego
Acton Pharmaceuticals Snares $15M for Inhaled Asthma Drug 01/06/10 Boston
Novartis Parts Ways with Idera Pharma 11/25/09 Boston
Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug 11/12/09 San Diego
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs 11/02/09 Boston
AstraZeneca Plans Local Job Cuts, Report Says 09/11/09 Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment 06/09/09 Boston
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells 05/18/09 Boston
Altair Therapeutics Changes CEO 05/14/09 San Diego
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation 05/05/09 Seattle
Axikin Raises $3M After Spinning Out From Actimis 01/22/09 San Diego
Page 1 of 2 next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.